April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Differential Availability of Active Lacritin and Cell Targeting Machinery in Normal vs Aqueous Deficient Tears as Insight into Cause
Author Affiliations & Notes
  • Gordon Laurie
    Cell Biology, Univ. of Virginia, Charlottesville, VA
    Ophthalmology, University of Virginia, Charlottesville, VA
  • Ningning Wang
    Cell Biology, Univ. of Virginia, Charlottesville, VA
  • Robert L McKown
    Integrated Science and Technology, James Madison University, Harrisonburg, VA
  • Denise S. Ryan
    Warfighter Refractive Surgery and Research Center at Fort Belvoir, Fort Belvoir, VA
  • Rose Kristine Sia
    Warfighter Refractive Surgery and Research Center at Fort Belvoir, Fort Belvoir, VA
  • Lamarr Peppers
    Warfighter Refractive Surgery and Research Center at Fort Belvoir, Fort Belvoir, VA
  • Footnotes
    Commercial Relationships Gordon Laurie, TearSolutions LLC (I), UVa Licensing and Ventures Group (P); Ningning Wang, None; Robert McKown, EyeRx (F), UVa Licensing and Ventures Group (P); Denise Ryan, None; Rose Sia, None; Lamarr Peppers, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3680. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gordon Laurie, Ningning Wang, Robert L McKown, Denise S. Ryan, Rose Kristine Sia, Lamarr Peppers; Differential Availability of Active Lacritin and Cell Targeting Machinery in Normal vs Aqueous Deficient Tears as Insight into Cause. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3680.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The monomeric form of tear lacritin is a multifunctional factor responsible for alleviating ocular surface stress. It is also an agonist for basal tearing. Monomeric lacritin targets a heparanase (HPSE) deglycanated form of cell surface syndecan-1 (SDC1). However, the lacritin-C splice variant, and lacritin polymerized by tear tissue transglutaminase, are both unable to target SDC1 and are therefore inactive. Here we ask whether either might displace monomeric lacritin in dry eye tears, and if SDC1 or HPSE may be inadequate.

Methods: Tears were collected onto Schirmer strips from 146 individuals before and 1 day, 1 week and 1 month after photorefractive keratectomy. Tears were stored at -70 C, and later eluted with a tear equivalent volume of PBS, and pooled by time and normal (≥ 15mm) vs dry eye (≤ 5 mm) tears. Tears were separated by SDS-PAGE and blotted with anti-N-terminal specific lacritin mab 1F5, anti-C-terminal specific lacritin ab ‘ab C-term’, anti-lacritin-C splice variant mab 4F6, anti-SDC1 mab A-38B, and with anti-heparanase abs #733 and #1453. Secondary abs were precleared over a tear column, and ab C-term was precleared over C-59 lacritin truncation mutant.

Results: Ab C-term detected less lacritin monomer in dry eye vs normal tears, a deficiency apparently compensated in dry eye by enhanced lacritin-C splice variant. The 1F5 mab epitope is shared by both forms, and thus the presumed hybrid band appeared greater in dry eye. Normal tears were enriched in latent (uncleaved) HPSE and deglycanated SDC1. 1 day after PRK, lacritin-C was further increased in dry eye, and both SDC1 and HPSE less in normals. Return to pre-PRK conditions was apparent by 1 month.

Conclusions: Aqueous deficient dry eye tears are associated with decreased lacritin monomer, increased lacritin-C splice variant, and less deglycanted SDC1 and latent HPSE. These conditions are appropriate for the exacerbation or initiation of dry eye.

Keywords: 486 cornea: tears/tear film/dry eye • 480 cornea: basic science • 686 refractive surgery: PRK  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×